Form 4: Integra LifeSciences Director Shaundra Clay Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Shaundra Clay reports acquiring and disposing of Integra LifeSciences common stock on May 9, 2024.
Summary
- On May 9, 2024, Shaundra Clay, a director of Integra LifeSciences Holdings Corp, engaged in transactions involving the company's common stock.
- Clay acquired 8,696 shares of common stock.
- Simultaneously, Clay disposed of 21,923 shares of common stock.
- Following these transactions, Clay beneficially owns 21,923 shares of Integra LifeSciences.
- The acquisition was priced at $0.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company director, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence for publicly traded companies.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of stock acquisition and disposal transaction. |
| 05/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.